ID   OPA1_RAT                Reviewed;         960 AA.
AC   Q2TA68; O08681; Q5MPP1; Q5MPP2; Q5QJE9; Q6B435; Q6R611;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2006, sequence version 1.
DT   02-OCT-2024, entry version 135.
DE   RecName: Full=Dynamin-like GTPase OPA1, mitochondrial;
DE            EC=3.6.5.5 {ECO:0000250|UniProtKB:O60313};
DE   AltName: Full=Optic atrophy protein 1 homolog;
DE   Contains:
DE     RecName: Full=Dynamin-like GTPase OPA1, long form {ECO:0000305};
DE              Short=L-OPA1 {ECO:0000250|UniProtKB:O60313};
DE   Contains:
DE     RecName: Full=Dynamin-like GTPase OPA1, short form {ECO:0000305};
DE              Short=S-OPA1 {ECO:0000250|UniProtKB:O60313};
DE   Flags: Precursor;
GN   Name=Opa1 {ECO:0000312|EMBL:AAI11072.1};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAR04100.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), AND TISSUE SPECIFICITY.
RC   TISSUE=Retinal ganglion {ECO:0000269|PubMed:15505078};
RX   PubMed=15505078; DOI=10.1167/iovs.03-1261;
RA   Pesch U.E.A., Fries J.E., Bette S., Kalbacher H., Wissinger B.,
RA   Alexander C., Kohler K.;
RT   "OPA1, the disease gene for autosomal dominant optic atrophy, is
RT   specifically expressed in ganglion cells and intrinsic neurons of the
RT   retina.";
RL   Invest. Ophthalmol. Vis. Sci. 45:4217-4225(2004).
RN   [2] {ECO:0000312|EMBL:AAS79791.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain {ECO:0000312|EMBL:AAS79791.1};
RX   PubMed=16249510; DOI=10.1167/iovs.03-1407;
RA   Kamei S., Chen-Kuo-Chang M., Cazevieille C., Lenaers G., Olichon A.,
RA   Belenguer P., Roussignol G., Renard N., Eybalin M., Michelin A.,
RA   Delettre C., Brabet P., Hamel C.P.;
RT   "Expression of the Opa1 mitochondrial protein in retinal ganglion cells:
RT   its downregulation causes aggregation of the mitochondrial network.";
RL   Invest. Ophthalmol. Vis. Sci. 46:4288-4294(2005).
RN   [3] {ECO:0000312|EMBL:AAI11072.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Liver {ECO:0000312|EMBL:AAI11072.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4] {ECO:0000305, ECO:0000312|EMBL:AAT92526.1}
RP   PROTEIN SEQUENCE OF 302-312; 416-423; 446-460; 801-818 AND 825-834, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Hippocampus;
RA   Lubec G., Diao W.;
RL   Submitted (APR-2007) to UniProtKB.
RN   [5] {ECO:0000305, ECO:0000312|EMBL:AAB51724.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 556-960.
RC   STRAIN=R21 {ECO:0000312|EMBL:AAB51724.1};
RC   TISSUE=Spleen {ECO:0000312|EMBL:AAB51724.1};
RA   Yuan X.J., Salgar S.K., Kunz H.W., Gill T.J. III;
RT   "A novel gene in the rat genome.";
RL   Rat Genome 2:150-153(1996).
RN   [6] {ECO:0000305, ECO:0000312|EMBL:AAT92526.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 686-788.
RC   STRAIN=OFA {ECO:0000312|EMBL:AAT92526.1}; TISSUE=Intestine;
RA   Fabregas P.J., Nebot-Cegarra J., Capella G., Peinado M.A.;
RT   "Differential gene expression in gut during rat fetal period.";
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7] {ECO:0000305}
RP   PROTEIN SEQUENCE OF N-TERMINUS, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16778770; DOI=10.1038/sj.emboj.7601184;
RA   Ishihara N., Fujita Y., Oka T., Mihara K.;
RT   "Regulation of mitochondrial morphology through proteolytic cleavage of
RT   OPA1.";
RL   EMBO J. 25:2966-2977(2006).
CC   -!- FUNCTION: Dynamin-related GTPase that is essential for normal
CC       mitochondrial morphology by mediating fusion of the mitochondrial inner
CC       membranes, regulating cristae morphology and maintaining respiratory
CC       chain function (PubMed:16778770). Exists in two forms: the
CC       transmembrane, long form (Dynamin-like GTPase OPA1, long form; L-OPA1),
CC       which is tethered to the inner mitochondrial membrane, and the short
CC       soluble form (Dynamin-like GTPase OPA1, short form; S-OPA1), which
CC       results from proteolytic cleavage and localizes in the intermembrane
CC       space (By similarity). Both forms (L-OPA1 and S-OPA1) cooperate to
CC       catalyze the fusion of the mitochondrial inner membrane (By
CC       similarity). The equilibrium between L-OPA1 and S-OPA1 is essential:
CC       excess levels of S-OPA1, produced by cleavage by OMA1 following loss of
CC       mitochondrial membrane potential, lead to an impaired equilibrium
CC       between L-OPA1 and S-OPA1, inhibiting mitochondrial fusion (By
CC       similarity). The balance between L-OPA1 and S-OPA1 also influences
CC       cristae shape and morphology (By similarity). Involved in remodeling
CC       cristae and the release of cytochrome c during apoptosis (By
CC       similarity). Proteolytic processing by PARL in response to intrinsic
CC       apoptotic signals may lead to disassembly of OPA1 oligomers and release
CC       of the caspase activator cytochrome C (CYCS) into the mitochondrial
CC       intermembrane space (By similarity). Acts as a regulator of T-helper
CC       Th17 cells, which are characterized by cells with fused mitochondria
CC       with tight cristae, by mediating mitochondrial membrane remodeling:
CC       OPA1 is required for interleukin-17 (IL-17) production (By similarity).
CC       Its role in mitochondrial morphology is required for mitochondrial
CC       genome maintenance (By similarity). {ECO:0000250|UniProtKB:O60313,
CC       ECO:0000250|UniProtKB:P58281, ECO:0000269|PubMed:16778770}.
CC   -!- FUNCTION: [Dynamin-like GTPase OPA1, long form]: Constitutes the
CC       transmembrane long form (L-OPA1) that plays a central role in
CC       mitochondrial inner membrane fusion and cristae morphology (By
CC       similarity). L-OPA1 and the soluble short form (S-OPA1) form higher-
CC       order helical assemblies that coordinate the fusion of mitochondrial
CC       inner membranes (By similarity). Inner membrane-anchored L-OPA1
CC       molecules initiate membrane remodeling by recruiting soluble S-OPA1 to
CC       rapidly polymerize into a flexible cylindrical scaffold encaging the
CC       mitochondrial inner membrane (By similarity). Once at the membrane
CC       surface, the formation of S-OPA1 helices induce bilayer curvature (By
CC       similarity). OPA1 dimerization through the paddle region, which inserts
CC       into cardiolipin-containing membrane, promotes GTP hydrolysis and the
CC       helical assembly of a flexible OPA1 lattice on the membrane, which
CC       drives membrane curvature and mitochondrial fusion (By similarity).
CC       Plays a role in the maintenance and remodeling of mitochondrial
CC       cristae, some invaginations of the mitochondrial inner membrane that
CC       provide an increase in the surface area (By similarity). Probably acts
CC       by forming helical filaments at the inside of inner membrane tubes with
CC       the shape and dimensions of crista junctions (By similarity). The
CC       equilibrium between L-OPA1 and S-OPA1 influences cristae shape and
CC       morphology: increased L-OPA1 levels promote cristae stacking and
CC       elongated mitochondria, while increased S-OPA1 levels correlated with
CC       irregular cristae packing and round mitochondria shape (By similarity).
CC       {ECO:0000250|UniProtKB:G0SGC7, ECO:0000250|UniProtKB:O60313,
CC       ECO:0000250|UniProtKB:P58281}.
CC   -!- FUNCTION: [Dynamin-like GTPase OPA1, short form]: Constitutes the
CC       soluble short form (S-OPA1) generated by cleavage by OMA1, which plays
CC       a central role in mitochondrial inner membrane fusion and cristae
CC       morphology (By similarity). The transmembrane long form (L-OPA1) and
CC       the S-OPA1 form higher-order helical assemblies that coordinate the
CC       fusion of mitochondrial inner membranes (By similarity). Inner
CC       membrane-anchored L-OPA1 molecules initiate membrane remodeling by
CC       recruiting soluble S-OPA1 to rapidly polymerize into a flexible
CC       cylindrical scaffold encaging the mitochondrial inner membrane (By
CC       similarity). Once at the membrane surface, the formation of S-OPA1
CC       helices induce bilayer curvature (By similarity). OPA1 dimerization
CC       through the paddle region, which inserts into cardiolipin-containing
CC       membrane, promotes GTP hydrolysis and the helical assembly of a
CC       flexible OPA1 lattice on the membrane, which drives membrane curvature
CC       and mitochondrial fusion (By similarity). Excess levels of S-OPA1
CC       produced by cleavage by OMA1 following stress conditions that induce
CC       loss of mitochondrial membrane potential, lead to an impaired
CC       equilibrium between L-OPA1 and S-OPA1, thereby inhibiting mitochondrial
CC       fusion (By similarity). Involved in mitochondrial safeguard in response
CC       to transient mitochondrial membrane depolarization by mediating
CC       flickering: cleavage by OMA1 leads to excess production of S-OPA1,
CC       preventing mitochondrial hyperfusion (By similarity). Plays a role in
CC       the maintenance and remodeling of mitochondrial cristae, some
CC       invaginations of the mitochondrial inner membrane that provide an
CC       increase in the surface area (By similarity). Probably acts by forming
CC       helical filaments at the inside of inner membrane tubes with the shape
CC       and dimensions of crista junctions (By similarity). The equilibrium
CC       between L-OPA1 and S-OPA1 influences cristae shape and morphology:
CC       increased L-OPA1 levels promote cristae stacking and elongated
CC       mitochondria, while increased S-OPA1 levels correlated with irregular
CC       cristae packing and round mitochondria shape (By similarity).
CC       {ECO:0000250|UniProtKB:G0SGC7, ECO:0000250|UniProtKB:O60313,
CC       ECO:0000250|UniProtKB:P58281}.
CC   -!- FUNCTION: [Isoform 2]: Isoforms that contain the alternative exon 4b
CC       are required for mitochondrial genome maintenance, possibly by
CC       anchoring the mitochondrial nucleoids to the inner mitochondrial
CC       membrane. {ECO:0000250|UniProtKB:O60313}.
CC   -!- FUNCTION: [Isoform 3]: Isoforms that contain the alternative exon 4b
CC       are required for mitochondrial genome maintenance, possibly by
CC       anchoring the mitochondrial nucleoids to the inner mitochondrial
CC       membrane. {ECO:0000250|UniProtKB:O60313}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GTP + H2O = GDP + H(+) + phosphate; Xref=Rhea:RHEA:19669,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:37565,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:58189; EC=3.6.5.5;
CC         Evidence={ECO:0000250|UniProtKB:O60313};
CC   -!- ACTIVITY REGULATION: Activated by guanine nucleotide exchange factor
CC       RCC1L. {ECO:0000250|UniProtKB:O60313}.
CC   -!- SUBUNIT: Oligomeric complex consisting of membrane-bound and soluble
CC       forms of OPA1. Interacts with RCC1L; RCC1L acts as a guanine nucleotide
CC       exchange factor (GEF) for OPA1 by exchanging bound GDP for free GTP.
CC       Interacts with CHCHD3 and IMMT; these interactions occur preferentially
CC       with soluble OPA1 forms. Interacts with PRELID1.
CC       {ECO:0000250|UniProtKB:O60313}.
CC   -!- SUBCELLULAR LOCATION: [Dynamin-like GTPase OPA1, long form]:
CC       Mitochondrion inner membrane {ECO:0000269|PubMed:16778770}; Single-pass
CC       membrane protein {ECO:0000255}. Note=Detected at contact sites between
CC       endoplasmic reticulum and mitochondrion membranes.
CC       {ECO:0000250|UniProtKB:O60313}.
CC   -!- SUBCELLULAR LOCATION: [Dynamin-like GTPase OPA1, short form]:
CC       Mitochondrion intermembrane space {ECO:0000250|UniProtKB:O60313}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Additional isoforms may exist. {ECO:0000305};
CC       Name=1 {ECO:0000303|PubMed:15505078};
CC         IsoId=Q2TA68-1; Sequence=Displayed;
CC       Name=2 {ECO:0000303|PubMed:15505078};
CC         IsoId=Q2TA68-2; Sequence=VSP_052186, VSP_052187;
CC       Name=3 {ECO:0000303|PubMed:15505078}; Synonyms=7
CC       {ECO:0000303|PubMed:16778770};
CC         IsoId=Q2TA68-3; Sequence=VSP_052187;
CC   -!- TISSUE SPECIFICITY: Expressed in brain as well as retinal ganglion,
CC       starbust amacrine and horizontal cells of the retina. Absent from nerve
CC       fibers and photoreceptor cells of the retina.
CC       {ECO:0000269|PubMed:15505078}.
CC   -!- DOMAIN: The paddle region plays a major role in driving mitochondrial
CC       inner membrane fusion. It binds lipid membranes enriched in negatively
CC       charged phospholipids, such as cardiolipin, and promotes membrane
CC       tubulation. A conserved intramembrane region, named membrane insertion
CC       loop (MIL), within the paddle region inserts deeply into the bilayer,
CC       further stabilizing the interactions with cardiolipin-enriched
CC       membranes. OPA1 dimerization through the paddle domain promotes the
CC       helical assembly of a flexible OPA1 lattice on the membrane, driving
CC       mitochondrial fusion in cells. {ECO:0000250|UniProtKB:O60313}.
CC   -!- PTM: Cleaved by OMA1 or YME1L downstream of the transmembrane region in
CC       response to different signals to generate soluble forms. Cleaved by
CC       OMA1 at position S1 following stress conditions, generating the short
CC       soluble form (Dynamin-like GTPase OPA1, short form; S-OPA1). AFG3L2 is
CC       involved in the regulation of OMA1-dependent processing of OPA1 (By
CC       similarity). PARL-dependent proteolytic processing releases an
CC       antiapoptotic soluble form not required for mitochondrial fusion (By
CC       similarity). {ECO:0000250|UniProtKB:O60313,
CC       ECO:0000250|UniProtKB:P58281}.
CC   -!- PTM: [Isoform 2]: Cleavage at position S2 by YME1L is required to
CC       mediate oxidative phosphorylation (OXPHOS)-induced mitochondrial
CC       fusion. Cleavage occurs in the sequence motif Leu-Gln-Gln-Gln-Ile-Gln
CC       (LQQQIQ). {ECO:0000305|PubMed:16778770}.
CC   -!- PTM: [Isoform 3]: Cleavage at position S2 by YME1L is required to
CC       mediate oxidative phosphorylation (OXPHOS)-induced mitochondrial
CC       fusion. Cleavage occurs in the sequence motif Leu-Gln-Gln-Gln-Ile-Gln
CC       (LQQQIQ). {ECO:0000305|PubMed:16778770}.
CC   -!- SIMILARITY: Belongs to the TRAFAC class dynamin-like GTPase
CC       superfamily. Dynamin/Fzo/YdjA family. {ECO:0000255|PROSITE-
CC       ProRule:PRU01055}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB51724.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY333988; AAR04100.1; -; mRNA.
DR   EMBL; AY660011; AAV97815.1; -; mRNA.
DR   EMBL; AY660012; AAV97816.1; -; mRNA.
DR   EMBL; AY510274; AAS79791.1; -; mRNA.
DR   EMBL; BC111071; AAI11072.1; -; mRNA.
DR   EMBL; U93197; AAB51724.1; ALT_INIT; mRNA.
DR   EMBL; AY683458; AAT92526.1; -; mRNA.
DR   RefSeq; NP_598269.3; NM_133585.3. [Q2TA68-1]
DR   RefSeq; XP_006248560.1; XM_006248498.1. [Q2TA68-3]
DR   AlphaFoldDB; Q2TA68; -.
DR   SMR; Q2TA68; -.
DR   BioGRID; 251124; 4.
DR   IntAct; Q2TA68; 4.
DR   MINT; Q2TA68; -.
DR   STRING; 10116.ENSRNOP00000002343; -.
DR   iPTMnet; Q2TA68; -.
DR   PhosphoSitePlus; Q2TA68; -.
DR   SwissPalm; Q2TA68; -.
DR   jPOST; Q2TA68; -.
DR   PaxDb; 10116-ENSRNOP00000059078; -.
DR   Ensembl; ENSRNOT00000111984.1; ENSRNOP00000079139.1; ENSRNOG00000001717.9. [Q2TA68-3]
DR   GeneID; 171116; -.
DR   KEGG; rno:171116; -.
DR   UCSC; RGD:708423; rat. [Q2TA68-1]
DR   AGR; RGD:708423; -.
DR   CTD; 4976; -.
DR   RGD; 708423; Opa1.
DR   VEuPathDB; HostDB:ENSRNOG00000001717; -.
DR   eggNOG; KOG0447; Eukaryota.
DR   GeneTree; ENSGT00550000074851; -.
DR   HOGENOM; CLU_012302_0_0_1; -.
DR   InParanoid; Q2TA68; -.
DR   OrthoDB; 48011at2759; -.
DR   Reactome; R-RNO-169911; Regulation of Apoptosis.
DR   PRO; PR:Q2TA68; -.
DR   Proteomes; UP000002494; Chromosome 11.
DR   Bgee; ENSRNOG00000001717; Expressed in heart and 19 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0030425; C:dendrite; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0005874; C:microtubule; IBA:GO_Central.
DR   GO; GO:0030061; C:mitochondrial crista; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IDA:RGD.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0031966; C:mitochondrial membrane; IBA:GO_Central.
DR   GO; GO:0005741; C:mitochondrial outer membrane; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0005739; C:mitochondrion; ISO:RGD.
DR   GO; GO:1901612; F:cardiolipin binding; ISS:UniProtKB.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003924; F:GTPase activity; ISS:UniProtKB.
DR   GO; GO:0140523; F:GTPase-dependent fusogenic activity; ISS:UniProtKB.
DR   GO; GO:0019900; F:kinase binding; IPI:RGD.
DR   GO; GO:0180020; F:membrane bending activity; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008017; F:microtubule binding; IBA:GO_Central.
DR   GO; GO:0070300; F:phosphatidic acid binding; ISS:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0036444; P:calcium import into the mitochondrion; IMP:RGD.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IEP:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:1905232; P:cellular response to L-glutamate; IEP:RGD.
DR   GO; GO:0090398; P:cellular senescence; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0090102; P:cochlea development; IEP:RGD.
DR   GO; GO:0042407; P:cristae formation; ISO:RGD.
DR   GO; GO:0046039; P:GTP metabolic process; ISS:UniProtKB.
DR   GO; GO:0007007; P:inner mitochondrial membrane organization; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0048312; P:intracellular distribution of mitochondria; IMP:RGD.
DR   GO; GO:0097749; P:membrane tubulation; ISS:UniProtKB.
DR   GO; GO:0008053; P:mitochondrial fusion; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0000002; P:mitochondrial genome maintenance; ISS:UniProtKB.
DR   GO; GO:1990627; P:mitochondrial inner membrane fusion; ISS:UniProtKB.
DR   GO; GO:0007005; P:mitochondrion organization; IDA:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:1902236; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; ISS:ParkinsonsUK-UCL.
DR   GO; GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0090201; P:negative regulation of release of cytochrome c from mitochondria; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0001843; P:neural tube closure; ISO:RGD.
DR   GO; GO:1900078; P:positive regulation of cellular response to insulin stimulus; IMP:RGD.
DR   GO; GO:1900006; P:positive regulation of dendrite development; IMP:RGD.
DR   GO; GO:0061003; P:positive regulation of dendritic spine morphogenesis; IMP:RGD.
DR   GO; GO:0046628; P:positive regulation of insulin receptor signaling pathway; IMP:RGD.
DR   GO; GO:0032740; P:positive regulation of interleukin-17 production; ISS:UniProtKB.
DR   GO; GO:0010636; P:positive regulation of mitochondrial fusion; IMP:RGD.
DR   GO; GO:0014042; P:positive regulation of neuron maturation; IMP:RGD.
DR   GO; GO:2000330; P:positive regulation of T-helper 17 cell lineage commitment; ISS:UniProtKB.
DR   GO; GO:0051259; P:protein complex oligomerization; ISO:RGD.
DR   GO; GO:1904643; P:response to curcumin; IEP:RGD.
DR   GO; GO:0051602; P:response to electrical stimulus; IEP:RGD.
DR   GO; GO:0014850; P:response to muscle activity; IEP:RGD.
DR   GO; GO:0031667; P:response to nutrient levels; IEP:RGD.
DR   GO; GO:0060041; P:retina development in camera-type eye; IEP:RGD.
DR   GO; GO:0007601; P:visual perception; ISS:ParkinsonsUK-UCL.
DR   CDD; cd08771; DLP_1; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR022812; Dynamin.
DR   InterPro; IPR001401; Dynamin_GTPase.
DR   InterPro; IPR045063; Dynamin_N.
DR   InterPro; IPR030381; G_DYNAMIN_dom.
DR   InterPro; IPR045817; OPA1_C.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR11566; DYNAMIN; 1.
DR   PANTHER; PTHR11566:SF67; DYNAMIN-LIKE 120 KDA PROTEIN, MITOCHONDRIAL; 1.
DR   Pfam; PF00350; Dynamin_N; 1.
DR   Pfam; PF19434; OPA1_C; 1.
DR   PRINTS; PR00195; DYNAMIN.
DR   SMART; SM00053; DYNc; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS51718; G_DYNAMIN_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Apoptosis; Coiled coil;
KW   Direct protein sequencing; Disulfide bond; GTP-binding; Hydrolase;
KW   Lipid-binding; Magnesium; Membrane; Metal-binding; Mitochondrion;
KW   Mitochondrion inner membrane; Nucleotide-binding; Reference proteome;
KW   Transit peptide; Transmembrane; Transmembrane helix.
FT   TRANSIT         1..87
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000269|PubMed:16778770"
FT   CHAIN           88..960
FT                   /note="Dynamin-like GTPase OPA1, long form"
FT                   /id="PRO_0000257994"
FT   CHAIN           195..960
FT                   /note="Dynamin-like GTPase OPA1, short form"
FT                   /evidence="ECO:0000269|PubMed:16778770,
FT                   ECO:0000305|PubMed:16778770"
FT                   /id="PRO_0000257995"
FT   TOPO_DOM        88..96
FT                   /note="Mitochondrial matrix"
FT                   /evidence="ECO:0000305|PubMed:16778770"
FT   TRANSMEM        97..113
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        114..770
FT                   /note="Mitochondrial intermembrane"
FT                   /evidence="ECO:0000305|PubMed:16778770"
FT   INTRAMEM        771..781
FT                   /evidence="ECO:0000250|UniProtKB:O60313"
FT   TOPO_DOM        782..960
FT                   /note="Mitochondrial intermembrane"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          285..561
FT                   /note="Dynamin-type G"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          295..302
FT                   /note="G1 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          321..324
FT                   /note="G2 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          398..401
FT                   /note="G3 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          467..470
FT                   /note="G4 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          501..504
FT                   /note="G5 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          589..836
FT                   /note="Stalk region"
FT                   /evidence="ECO:0000250|UniProtKB:O60313"
FT   REGION          736..856
FT                   /note="Paddle region"
FT                   /evidence="ECO:0000250|UniProtKB:O60313"
FT   REGION          874..928
FT                   /note="Stalk region"
FT                   /evidence="ECO:0000250|UniProtKB:O60313"
FT   COILED          210..254
FT                   /evidence="ECO:0000255"
FT   COILED          895..960
FT                   /evidence="ECO:0000255"
FT   BINDING         298
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:O60313"
FT   BINDING         300
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:O60313"
FT   BINDING         301
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:O60313"
FT   BINDING         302
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:O60313"
FT   BINDING         302
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:O60313"
FT   BINDING         303
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:O60313"
FT   BINDING         317
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:O60313"
FT   BINDING         323
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:O60313"
FT   BINDING         398
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:O60313"
FT   BINDING         468
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:O60313"
FT   BINDING         470
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:O60313"
FT   BINDING         503
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:O60313"
FT   SITE            194..195
FT                   /note="Cleavage at site S1"
FT                   /evidence="ECO:0000269|PubMed:16778770"
FT   MOD_RES         228
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O60313"
FT   DISULFID        856..874
FT                   /evidence="ECO:0000250|UniProtKB:O60313"
FT   VAR_SEQ         158
FT                   /note="S -> PKLVSEVIEASEPLLLLS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15505078"
FT                   /id="VSP_052186"
FT   VAR_SEQ         209
FT                   /note="V -> GLLGELILLQQQIQEHEEEARRAAGQYSTSYAQQKRKV (in
FT                   isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15505078"
FT                   /id="VSP_052187"
FT   CONFLICT        187
FT                   /note="T -> S (in Ref. 1; AAR04100)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        316
FT                   /note="R -> P (in Ref. 2; AAS79791)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        687
FT                   /note="E -> G (in Ref. 6; AAT92526)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        692
FT                   /note="E -> G (in Ref. 6; AAT92526)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        730
FT                   /note="L -> P (in Ref. 6; AAT92526)"
FT                   /evidence="ECO:0000305"
FT   MOTIF           Q2TA68-2:234..239
FT                   /note="LQQQIQ motif"
FT                   /evidence="ECO:0000269|PubMed:16778770"
FT   MOTIF           Q2TA68-3:217..222
FT                   /note="LQQQIQ motif"
FT                   /evidence="ECO:0000269|PubMed:16778770"
SQ   SEQUENCE   960 AA;  111307 MW;  0C4BE54FCD7A53B3 CRC64;
     MWRAGRAALA CEVCQSLVKH SSGVQRNVPL QKLHLVSRSI YRSHHPALKL QRPQLRTSFQ
     QFSSLTNLSL HKLKLSPTKY GYQPRRNFWP ARLAARLLKL RYIILGSAVG GGYTAKKTFD
     EWKDMIPDLS DYKWIVPDFI WEIDEYIDLE KIRKALPSSE DLANFAPDLD KIAESLSLLK
     DFFTAGTPGE TAFRATDHGS ESDKHYRKVS DKEKIDQLQE ELLHTQLKYQ RILERLEKEN
     KELRKLVLQK DDKGIHHRKL KKSLIDMYSE VLDVLSDYDA SYNTQDHLPR VVVVGDQSAG
     KTSVLEMIAQ ARIFPRGSGE MMTRSPVKVT LSEGPHHVAL FKDSSREFDL TKEEDLAALR
     HEIELRMRKN VKEGCTVSPE TISLNVKGPG LQRMVLVDLP GVINTVTSGM APDTKETIFS
     ISKAYMQNPN AIILCIQDGS VDAERSIVTD LVSQMDPHGR RTIFVLTKVD LAEKNVASPS
     RIQQIIEGKL FPMKALGYFA VVTGKGNSSE SIEAIREYEE EFFQNSKLLK TSMLKAHQVT
     TRNLSLAVSD CFWKMVRESV EQQADSFKAT RFNLETEWKN NYPRLRELDR NELFEKAKNE
     ILDEVISLSQ VTPKHWEEIL QQSLWERVST HVIENIYLPA AQTMNSGTFN TTVDIKLKQW
     TDKQLPNKAV EVAWETLQDE FSRFMTEPKG KEHDDIFDKL KEAVKEESIK RHKWNDFAED
     SLRVIQHNAL EDRSISDKQQ WDAAIYFMEE ALQGRLKDTE NAIENMIGPD WKKRWIYWKN
     RTQEQCVHNE TKNELEKMLK VNDEHPAYLA SDEITTVRKN LESRGVEVDP SLIKDTWHQV
     YRRHFLKTAL NHCNLCRRGF YYYQRHFIDS ELECNDVVLF WRIQRMLAIT ANTLRQQLTN
     TEVRRLEKNV KEVLEDFAED GEKKVKLLTG KRVQLAEDLK KVREIQEKLD AFIEALHQEK
//
